Because estrogen has been reported to regulate PLA2G2A activation,32 we evaluated tear fluid PLA2G2A levels and found that PLA2G2A was significantly higher in KC patients compared to non-KC patients (p < 0.01) (Figure 1B). The gene discussed is PLA2G2A; the disease is keratoconus.